{"entity":{"type":"insider","cik":"0001558093","url":"/insider/0001558093","json_url":"/insider/0001558093.json","name":"Volpe David Crispino","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2012-09-19","last":"2013-12-06","span_basis":"filed_date"},"name_variants":[{"name":"Volpe David Crispino","source":"filing","n_filings":7,"first_seen":"2012-09-19","last_seen":"2013-12-06"}],"transactions":[{"id":5556856,"accession":"0001011060-13-000044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001011060-13-000044","line_url":"/filing/0001011060-13-000044","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.0494,"price_display":"0.05","price_state":"stated","total_value":988.0,"total_display":"988.00","total_whole":"988","shares_owned_after":150153.0,"shares_owned_after_display":"150,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-03","filed_date":"2013-12-06","scope":"insider","n_lines":3},{"id":4769352,"accession":"0001011060-13-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-13-000032","line_url":"/filing/0001011060-13-000032#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":600.0,"total_display":"600.00","total_whole":"600","shares_owned_after":130153.0,"shares_owned_after_display":"130,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-29","filed_date":"2013-09-03","scope":"insider"},{"id":2775116,"accession":"0001011060-12-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000051","line_url":"/filing/0001011060-12-000051#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.032,"price_display":"0.03","price_state":"stated","total_value":320.0,"total_display":"320.00","total_whole":"320","shares_owned_after":120153.0,"shares_owned_after_display":"120,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-06","filed_date":"2012-12-10","scope":"insider"},{"id":2720888,"accession":"0001011060-12-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000047","line_url":"/filing/0001011060-12-000047#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.03,"price_display":"0.03","price_state":"stated","total_value":150.0,"total_display":"150.00","total_whole":"150","shares_owned_after":110153.0,"shares_owned_after_display":"110,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-30","filed_date":"2012-12-04","scope":"insider"},{"id":3463200,"accession":"0001011060-12-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001011060-12-000046","line_url":"/filing/0001011060-12-000046#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.04,"price_display":"0.04","price_state":"stated","total_value":200.0,"total_display":"200.00","total_whole":"200","shares_owned_after":105153.0,"shares_owned_after_display":"105,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-29","filed_date":"2012-12-03","scope":"insider"},{"id":3160533,"accession":"0001011060-12-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001011060-12-000044","line_url":"/filing/0001011060-12-000044","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.042,"price_display":"0.04","price_state":"stated","total_value":1050.0,"total_display":"1,050.00","total_whole":"1,050","shares_owned_after":90153.0,"shares_owned_after_display":"90,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-19","filed_date":"2012-11-21","scope":"insider","n_lines":2},{"id":3255888,"accession":"0001558093-12-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001558093-12-000003","line_url":"/filing/0001558093-12-000003","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.031,"price_display":"0.03","price_state":"stated","total_value":775.0,"total_display":"775.00","total_whole":"775","shares_owned_after":70153.0,"shares_owned_after_display":"70,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-18","filed_date":"2012-09-19","scope":"insider","n_lines":2},{"id":3255876,"accession":"0001558093-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001558093-12-000003","line_url":"/filing/0001558093-12-000003#line-1","is_derivative":false,"issuer_cik":"0001011060","issuer_name":"AdvanSource Biomaterials Corp","issuer_ticker":"ASNB","issuer_name_source":null,"issuer_url":"/issuer/0001011060","owner_cik":"0001558093","owner_name":"Volpe David Crispino","owner_display_name":"Volpe David Crispino","owner_url":"/insider/0001558093","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.02,"price_display":"0.02","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":50153.0,"shares_owned_after_display":"50,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-17","filed_date":"2012-09-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001011060","name":"AdvanSource Biomaterials Corp","url":"/issuer/0001011060","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2012-09-19","last_seen":"2013-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001558093","retrieved_at":"2026-08-22T19:37:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}